Alembic Pharma gets six USFDA approvals in Q2FY24 EP News Bureau Oct 4, 2023 Approvals include Chlorpromazine Hydrochloride Tablets USP, Brimonidine Tartrate Ophthalmic Solution, Guanfacine Extended-Release…
